Investors

Financial Information

한미약품의 경영지표를 확인하실 수 있습니다.

Summarized Income Statement

(1 million won , K-IFRS)
Quarterly and yearly information
Category 2021 2020 2019 2018 2017
Sales revenue 1,203,186 1,075,854 1,113,650 1,015,962 916,586
Cost of sales 570,433 494,935 481,167 475,047 398,182
Gross profit 632,752 580,918 632,482 540,916 518,404
Selling general administrative expenses 361,309 319,555 334,316 291,436 284,952
Ordinary development costs 146,027 212,387 194,288 165,906 151,289
Operating Income (Loss) 125,416 48,976 103,878 83,574 82,164
Finance income 9,229 4,380 11,552 6,863 5,117
Finance cost 18,763 32,656 25,877 25,068 10,700
Other income 10,727 14,740 10,843 8,563 9,350
Other expenses 22,912 13,310 17,126 23,578 27,081
Profit (loss) before tax 103,697 22,130 83,270 50,355 58,850
Income tax expense 22,218 4,841 19,402 16,199 (10,124)
Profit (loss) 81,478 17,290 63,867 34,156 68,974
Other comprehensive income 25,647 3,398 (21,284) (6,288) (4,616)
Total comprehensive income 107,125 20,688 42,583 27,868 64,357